Plasma glucose and insulin responses after consumption of breakfasts with different sources of soluble fiber in type 2 diabetes patients: A randomized crossover clinical trial

Abstract

Background: The amount and quality of carbohydrates are important determinants of plasma glucose after meals. Regarding fiber content, it is unclear whether the intake of soluble fibers from foods or supplements has an equally beneficial effect on lowering postprandial glucose. Objective: The aim of our study was to compare the acute effect of soluble fiber intake from foods or supplements after a common meal on postprandial plasma glucose and plasma insulin in patients with type 2 diabetes (T2D). Design: A randomized crossover clinical trial was conducted in patients with T2D. Patients consumed isocaloric breakfasts (mean ± SD: 369.8 ± 9.4 kcal) with high amounts of fiber from diet food sources (total fiber 9.7 g; soluble fiber 5.4 g), high amounts of soluble fiber from guar gum supplement (total fiber 9.1 g: soluble fiber 5.4 g), and normal amounts of fiber (total fiber 2.4 g; soluble fiber 0.8 g). Primary outcomes were postprandial plasma glucose and insulin (0-180 min). Data woe analyzed by repealed measures ANOVA and post hoc Bonferroni lest. Results: A total of 19 patients [aged 65.8 ± 7.3 y; median (IQR), 10 (5-9) y of T2D duration: glycated hemoglobin 7.0% ± 0.8%: body mass index (in kg/m2) 28.2 ± 2.9] completed 57 meal tests. After breakfast, the incremental area under the curve (iAUQ for plasma glucose [mg/dL · min: mean (95% CI)] did not differ between high fiber from diet (HFD) [7861 (6257, 9465)] and high fiber from supplement (HFS) [7847 (5605, 10,090)| (P = 1.00) and both were lower than usual fiber (UF) [9527 (7549, 11,504)1 (P = 0.014 and P = 0.037, respectively). iAUCs [μIU/mL · min: mean (95% CI)] did not differ (P = 0.877): HFD [3781 (2513, 5050)1, HFS [4006 (2711, 5302), and UF[4315 (3027,5603)). Conclusions: Higher fiber intake was associated with lower postprandial glucose at breakfast, and the intake of soluble fiber from food and supplement had a similar effect in patients with T2D. This trial was registered at clinicaltrials.gov as NCT02204384.